英文名称 | Valganciclovir |
---|---|
生化机理 |
Valganciclovir is an antiviral medication used to treat cytomegalovirus infections. As the L-valyl ester of ganciclovir, it is actually an orally administered prodrμg of the standard anti-cytomegalovirus (CMV) drμg ganciclovir. After oral administration, Valganciclovir is rapidly converted to ganciclovir by intestinal and hepatic esterases. |
储存温度 | 2-8°C储存 |
运输条件 | 冰袋运输 |
IUPAC Name | [2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-hydroxypropyl] acetate |
---|---|
INCHI | InChI=1S/C11H15N5O5/c1-6(18)20-3-7(2-17)21-5-16-4-13-8-9(16)14-11(12)15-10(8)19/h4,7,17H,2-3,5H2,1H3,(H3,12,14,15,19) |
InChi Key | YKLKCCHLLFMWQE-UHFFFAOYSA-N |
Canonical SMILES | CC(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N |
分子式 |
C11H15N5O5 |
PubChem CID | 135459820 |
分子量 | 297.27 |
溶解性 | DMSO |
---|
象形图 |
Health Hazard |
---|---|
信号词 | Warning |
危险声明 |
H341: Suspected of causing genetic defects H351: Suspected of causing cancer H361: Suspected of damaging fertility or the unborn child H362: May cause harm to breast-fed children |
预防措施声明 | P280,P405,P501,P264,P260,P281,P270,P263,P203,P318 |